Evaluation and Optimization of a Microcavity Plate–Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates
Drug Metabolism and Disposition · 2024
DOI: 10.1124/dmd.124.001653 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von David A Kukla und 2 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative, Translational, and ADME Sciences, AbbVie Inc., North Chicago, Illinois. Hauptthemen laut MEDLINE: Hepatocytes, Spheroids, Cellular, Metabolic Clearance Rate. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 91 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Quantitative, Translational, and ADME Sciences, AbbVie Inc., North Chicago, Illinois.
- Quantitative, Translational, and ADME Sciences, AbbVie Inc., North Chicago, Illinois david.stresser@abbvie.com.
ORCID-Profile: David A Kukla, David G Belair, David M Stresser
Zitieren
APA
Kukla, D. A., Belair, D. G., & Stresser, D. M. (2024). Evaluation and Optimization of a Microcavity Plate–Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.124.001653
Vancouver
Kukla DA, Belair DG, Stresser DM. Evaluation and Optimization of a Microcavity Plate–Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.124.001653
BibTeX
@article{Kukla2024,
author = {Kukla, David A and Belair, David G and Stresser, David M},
title = {Evaluation and Optimization of a Microcavity Plate–Based Human Hepatocyte Spheroid Model for Predicting Clearance of Slowly Metabolized Drug Candidates},
journal = {Drug Metabolism and Disposition},
year = {2024},
doi = {10.1124/dmd.124.001653}
}
EUVIMED